Unravelling the dual role of naringenin in response to cytotoxicity caused by indomethacin and diclofenac

Background: Indomethacin and diclofenac exhibited similar cytotoxic mechanisms, involving the generation of cell stress, disruption of mitochondria, and lysosome functions. Recently, we reported that naringenin, a natural bioactive flavonoid, elicited cytoprotection against indomethacin but not diclofenac in Caco-2 cells. Objectives: This study investigated whether these divergent effects were associated with lysosomal integrity and autophagy. Methods: Caco-2 cells were treated with naringenin (100 μM; non-cytotoxic concentration) for 24 h, followed by either indomethacin or diclofenac (1000 μM). After 72-h treatment, cell viability, apoptosis and lysosomal integrity were measured by methylthialazole tetrazolium, neutral red uptake, annexin V/propidium iodide staining, and acridine orange (AO) uptake assays. Protein expression was assessed by Western blot analysis. Results: Naringenin protected Caco-2 cells from indomethacin toxicity, evidenced by increased cell viability, reduced apoptosis, and heightened red fluorescence of AO compared to indomethacin-alone. In addition, it suppressed mammalian target of rapamycin (mTOR) expression, accompanied by a further increased light chain 3 (LC3) II/I ratio. Hence, its cytoprotection might link to inhibition of lysosomal membrane permeabilization (LMP) and induction of autophagy with autophagosome formation in indomethacin-treated cells. Conversely, in combination with diclofenac, naringenin elevated cytotoxicity and apoptosis, accompanied by a further decrease in AO signal compared to diclofenac alone. In addition to mTOR inhibition, it reduced LC3 II/I ratio and damage-regulated autophagy modulator level. Thus, despite autophagy activation, naringenin enhanced diclofenac toxicity by promoting the loss of LMP and a decrease in autophagosomes. Conclusion: The distinctive responses of naringenin to indomethacin and diclofenac could be attributed to its capacity to preserve lysosome integrity while modulating autophagosome dynamics.

Authors

Publication Details

Journal
The Thai Journal of Pharmaceutical Sciences
Published
2025-12-22
DOI
https://doi.org/10.56808/3027-7922.2947
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unravelling the dual role of naringenin in response to cytotoxicity caused by indomethacin and diclofenac

Suree Jianmongkol, Cherdsak Boonyong, Kaitsuda Saiprom
The Thai Journal of Pharmaceutical Sciences
Autophagy in Disease and Therapy
article

Unravelling the dual role of naringenin in response to cytotoxicity caused by indomethacin and diclofenac

Suree Jianmongkol, Cherdsak Boonyong, Kaitsuda Saiprom
article en

Abstract

Background: Indomethacin and diclofenac exhibited similar cytotoxic mechanisms, involving the generation of cell stress, disruption of mitochondria, and lysosome functions. Recently, we reported that naringenin, a natural bioactive flavonoid, elicited cytoprotection against indomethacin but not diclofenac in Caco-2 cells. Objectives: This study investigated whether these divergent effects were associated with lysosomal integrity and autophagy. Methods: Caco-2 cells were treated with naringenin (100 μM; non-cytotoxic concentration) for 24 h, followed by either indomethacin or diclofenac (1000 μM). After 72-h treatment, cell viability, apoptosis and lysosomal integrity were measured by methylthialazole tetrazolium, neutral red uptake, annexin V/propidium iodide staining, and acridine orange (AO) uptake assays. Protein expression was assessed by Western blot analysis. Results: Naringenin protected Caco-2 cells from indomethacin toxicity, evidenced by increased cell viability, reduced apoptosis, and heightened red fluorescence of AO compared to indomethacin-alone. In addition, it suppressed mammalian target of rapamycin (mTOR) expression, accompanied by a further increased light chain 3 (LC3) II/I ratio. Hence, its cytoprotection might link to inhibition of lysosomal membrane permeabilization (LMP) and induction of autophagy with autophagosome formation in indomethacin-treated cells. Conversely, in combination with diclofenac, naringenin elevated cytotoxicity and apoptosis, accompanied by a further decrease in AO signal compared to diclofenac alone. In addition to mTOR inhibition, it reduced LC3 II/I ratio and damage-regulated autophagy modulator level. Thus, despite autophagy activation, naringenin enhanced diclofenac toxicity by promoting the loss of LMP and a decrease in autophagosomes. Conclusion: The distinctive responses of naringenin to indomethacin and diclofenac could be attributed to its capacity to preserve lysosome integrity while modulating autophagosome dynamics.

The Thai Journal of Pharmaceutical SciencesVol. 49(4)
Openalex Percentile: Top 30%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.